Milestone Pharmaceuticals reported Q3 2026 results showing $1 million in CARDAMYST nasal spray sales, a 73% increase from Q2, with expanding prescriber and payer coverage. The company is implementing cost-efficiency measures to reduce operating expenses by about 30%, including bringing its sales force in-house and cutting less productive programs, aiming to extend its cash runway into late 2028. Leadership changes include departures of the CFO and CMO, while the Phase 3 trial for AFib-RVR treatment remains on schedule with data expected in the second half of 2028. These steps aim to support continued growth of CARDAMYST and advance the AFib-RVR program while preserving financial stability.
Milestone Pharmaceuticals' Q3 2026 financial results and cost-efficiency plans provide context for readers. For those following the health sector, 93 of 150 US health stocks on Pluang rose today, with notable movers including SLS at USD 9.47 (+17.93%), FLNA at USD 0.48 (+7.05%), and HRTX at USD 0.35 (+5.80%). This data is as of Nov 13, 2026 18:41 WIB.
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
Boralex Inc. announced the issuance of C$600 million in green bonds, split into two series with maturities in 2031 and 2036, bearing interest rates of 4.503% and 5.173% respectively. This marks Boralex's first green-labelled corporate securities offe...
Investec Bank Plc, acting as an exempt principal trader and advisor to DBAY Advisors Limited, disclosed the sale of 25,000 ordinary shares of Logistics Development Group Plc on November 12, 2026. The shares were sold at a price of 23 per unit. There ...
